US 12091661
Organic compositions to treat HSF1-related diseases
granted A61KA61K31/713A61K45/06
Quick answer
US patent 12091661 (Organic compositions to treat HSF1-related diseases) held by Arrowhead Pharmaceuticals, Inc. expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/713, A61K45/06, A61P, A61P19/02